Evaluating the Next Steps for Research in Myelofibrosis
Laura Michaelis, MD, discusses the next steps for research in the treatment of myelofibrosis following the addition of fedratinib (Inrebic) to the armamentarium of JAK inhibitors.
Related Articles
Role of Systemic Therapy in TACE-Eligible Patients
The panelist discusses how for patients initially eligible for embolization, systemic therapy may be combined with transarterial chemoembolization (TACE) upfront for high-risk disease (ie, large…
Experts Discuss Tislelizumab’s FDA Approval in Esophageal Cancer
Ken Kato, MD, PhD, and Harry H. Yoon, MD, MHS, discussed the recent FDA approval of tislelizumab in the first line for patients with esophageal…
Shouse Covers the Future of Lymphoma Therapy With Bispecific Antibodies
Geoffrey Shouse, DO, PhD, discusses the growing interest in bispecific antibodies within the field of oncology.
Novel rhPSMA Therapy Targets Advanced Prostate Cancer With Precision
177Lu rhPSMA-10.1 showed high tumor radiation with low healthy tissue exposure in a phase 1/2 trial for metastatic castration-resistant prostate cancer.
Discussing Lung Cancer NGS Testing and EGFR Treatment Strategies
During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their approaches.
Actimab-A Triplet Trial Launches in Frontline AML
A phase 1 trial is evaluating Actimab-A, venetoclax, and ASTX-727 in frontline acute myeloid leukemia, with initial data expected later this year.
A 62-Year-Old Man Who Is Newly Diagnosed With BPDCN
An expert discusses the patient case of a man aged 62 years who is newly diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The patient…
Eggener Urges Pragmatic Approach to Prostate Cancer Innovations
Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.”
Breakthroughs in Lung Cancer Research and Early Detection Strategies
Jennifer Marie Suga, MD, shares the lung cancer research she’s eager to explore as new data emerges.
Guidelines for Mesothelioma Now Offer More Treatment Options
Hedy Lee Kindler, MD, explains the new treatment updates for patients with mesothelioma.